References
- 1. D. Wang and R. N. DuBois, Eicosanoids and cancer, Nat. Rev. Cancer 10 (2010) 181-193; DOI: 10.1038/nrc2809.
- 2. E. R. Rayburn, S. J. Ezell and R. Zhang, Anti-inflammatory agents for cancer therapy, Mol. Cell. Pharmacol. 1 (2009) 29-43.
- 3. B. Zawidlak-Wegrzynska, M. Kawalec, I. Bosek, M. Luczyk-Juzwa, G. Adamus, A. Rusin, P. Filipczak, M. Glowala-Kosinska, K. Wolanska, Z. Krawczyk and P. Kurcok, Synthesis and antiproliferative properties of ibuprofen-oligo(3-hydroxybutyrate) conjugates, Eur. J. Med. Chem. 45 (2010) 1833-1842; DOI: 10.1016/j.ejmech.2010.01.020.
- 4. S. Fogli, I. Banti, F. Stefanelli, L. Picchianti, M. Digiacomo, M. Macchia, M. C. Breschi and A. Lapucci, Therapeutic potential of sulindac hydroxamic acid against human pancreatic and colonic cancer cells, Eur. J. Med. Chem. 45 (2010) 5100-5107; DOI: 10.1016/j.ejmech.2010.08.019.
- 5. W. Liu, J. Zhou, K. Bensdorf, H. Zhang, H. Liu, Y. Wang, H. Qian, Y. Zhang, A. Wellner, G. Rubner, W. Huang, C. Guo and R. Gust, Investigations on cytotoxicity and anti-inflammatory potency of licofelone derivatives, Eur. J. Med. Chem. 46 (2011) 907-913; DOI:10.1016/j.ejmech.2011. 01.002.
- 6. Z. Rajić, D. Hadjipavlou-Litina, E. Pontiki, M. Kralj, L. Šuman and B. Zorc, The novel ketoprofen amides - Synthesis and biological evaluation as antioxidants, lipoxygenase inhibitors and cytostatic agents, Chem. Biol. Drug Des. 75 (2010) 641-652; DOI: 10.1111/j.1747-0285.2010.00963.x.
- 7. Z. Rajić, D. Hadjipavlou-Litina, E. Pontiki, J. Balzarini and B. Zorc, The novel amidocarbamate derivatives of ketoprofen: Synthesis and biological activity, Med. Chem. Res. 20 (2010) 210-219; DOI: 10.1007/s00044-010-9309-2.
- 8. K. Wittine, K. Benci, Z. Rajić, B. Zorc, M. Kralj, M. Marjanović, K. Pavelić, E. De Clercq, G. Andrei, R. Snoeck, J. Balzarini and M. Mintas, The novel phosphoramidate prodrugs of NSAID 3-hydroxypropylamides: Synthesis, cytostatic and antiviral activity evaluations, Eur. J. Med. Chem. 44 (2009) 143-151; DOI: 10.1016/j.ejmech.2008.03.037.
- 9. I. Perković, I. Butula, M. Kralj, I. Martin-Kleiner, J. Balzarini, D. Hadjipavlou-Litina, A-M. Katsori and B. Zorc, Novel NSAID 1-acyl-4-cycloalkyl/arylsemicarbazides and 1-acyl-5-benzyloxy/ hydroxy)carbamoylcarbazides as potential anticancer agents and antioxidants, Eur. J. Med. Chem.51 (2012) 227-238; DOI: 10.1016/j.ejmch.2012.02.046.
- 10. Z. Rajić, I. Butula, B. Zorc, S. Kraljević Pavelić, K. Hock, K. Pavelić, L. Naesens, E. De Clercq, J. Balzarini, M. Przyborowska, T. Ossowski and M. Mintas, Cytostatic and antiviral evaluations of NSAID hydroxamic acids, Chem. Biol. Drug Des. 73 (2009) 328-338; DOI: 10.1111/j.1747-0285. 2009.00774x.
- 11. Z. Rajić, I. Perković, I. Butula, B. Zorc, D. Hadjipavlou-Litina, E. Pontiki, S. Pepeljnjak and I. Kosalec, Synthesis and biological evaluation of O-methyl and O-ethyl NSAID hydroxamic acids, J. Enzyme Inhib. Med. Chem. 24 (2009) 1179-1187; DOI: 10.1080/14756360902779128.
- 12. B. Zorc, S. Antolić and I. Butula, Macromolecular prodrugs. I. Synthesis of some non-steroidal anti-inflammatory drug esters, Acta Pharm. 43 (1993) 127-133.
- 13. M. Barbarić, M. Kralj, M. Marjanović, I. Husnjak, K. Pavelić, J. Filipović-Grčić, D. Zorc and B. Zorc, Synthesis and in vitro antitumor effect of diclofenac and fenoprofen thiolated and nonthiolated polyaspartamide-drug conjugates, Eur. J. Med. Chem. 42 (2007) 20-29; DOI: 10.1016/ j.ejmech.2006.08.009.
- 14. I. Kalčić, M. Zovko, M. Jadrijević-Mladar Takač, B. Zorc and I. Butula, Synthesis and reactions of some azolecarboxylic acid derivatives, Croat. Chem. Acta 76 (2003) 217-228.
- 15. I. Butula, B. Zorc and V. Vela, Reaktionen mit 1-Benzotriazol carbonsaurechlorid.VII. Die Umsetzung mit Aminosauren, Croat. Chem. Acta 54 (1981) 435-440. 418